Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Eur J Cancer. 2020 May 17;133:33–46. doi: 10.1016/j.ejca.2020.03.031

Fig. 7. Results of meta-analysis for survival impact of malignant peritoneal cytology.

Fig. 7.

Results of meta-analysis are shown for (A) DFS and (B) OS. Funnel plots are shown in Fig. S6. A forest plot from a random effects meta-analysis of seven studies for DFS and six studies for OS (including our study) stratified by inclusion criteria and ordered within stratum by year of publication and relative weight (%) of study. Heterogeneity was low to moderate across on disease-free survival (A, DFS: I2 = 50%, stage I endometrioid: I2 = 27%) and low across studies on overall survival (B, OS: I2 = 8%, stage I endometrioid: I2 = 0%). DFS, disease-free survival; OS, overall survival.